Investors Are Circling AXIM Biotechnologies, Inc. (OTCPK:AXIM), What Do the Numbers Tell Us?

The Value Composite Two of AXIM Biotechnologies, Inc. (OTCPK:AXIM) is 91. The VC2 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, price to earnings and shareholder yield.  Similarly, the Value Composite One (VC1) is a method that investors use to determine a company’s value.  The VC1 of AXIM Biotechnologies, Inc. (OTCPK:AXIM) is 87.  A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company.  The VC1 is calculated using the same metrics as VC2, but without taking into consideration shareholder yield.

There are many traders who think that proper psychology is one of the most important aspects of becoming successful in the stock market. Traders may need to learn how to become confident while overcoming certain fears and dealing with extreme ups and downs. This may not be easy as individuals all draw off of prior experiences at some level. Being able to convert outside success to the stock market may take some work. Traders who are able to overcome previous bias may be on the right path for having the proper mindset when entering the market.

We can now take a quick look at some historical stock price index data. AXIM Biotechnologies, Inc. (OTCPK:AXIM) presently has a 10 month price index of 1.77027. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 27.15026, the 24 month is 9.77612, and the 36 month is 3.27500. Narrowing in a bit closer, the 5 month price index is 0.49248, the 3 month is 0.68730, and the 1 month is currently 1.33673.

Watching some historical volatility numbers on shares of AXIM Biotechnologies, Inc. (OTCPK:AXIM), we can see that the 12 month volatility is presently 251.945100. The 6 month volatility is 92.754300, and the 3 month is spotted at 81.730600. Following volatility data can help measure how much the stock price has fluctuated over the specified time period. Although past volatility action may help project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time period. 

Valuation Scores

Shifting gears, we can see that AXIM Biotechnologies, Inc. (OTCPK:AXIM) has a Q.i. Value of 64.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be.

At the time of writing, AXIM Biotechnologies, Inc. (OTCPK:AXIM) has a Piotroski F-Score of 3. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.

AXIM Biotechnologies, Inc. has an M-score Beneish of -6.834188. This M-score model was developed by Messod Beneish in order to detect manipulation of financial statements. The score uses a combination of eight different variables. The specifics of the variables and formula can be found in the Beneish paper “The Detection of Earnings Manipulation”.

Investors may be interested in viewing the Gross Margin score on shares of AXIM Biotechnologies, Inc. (OTCPK:AXIM). The name currently has a score of 61.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

AXIM Biotechnologies, Inc. (OTCPK:AXIM) has a current MF Rank of 13921. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks. AXIM Biotechnologies, Inc. has a current ERP5 Rank of 15706. The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.

Leave A Reply

Your email address will not be published.